Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Faron Pharmaceuticals OyAnnouncement

Yesterday 07:00

Faron Pharmaceuticals Ltd | Company announcement | May 18, 2026 at 09:00:00
EEST

TR-1: Standard form for notification of major holdings

+--------------+----------+-----------+--------------+-------+-----------+---+
| NOTIFICATION |          |           |              |       |           |   |
| OF MAJOR     |          |           |              |       |           |   |
| HOLDINGS (to |          |           |              |       |           |   |
| be sent to   |          |           |              |       |           |   |
| the relevant |          |           |              |       |           |   |
| issuer and   |          |           |              |       |           |   |
| to the FCA   |          |           |              |       |           |   |
| in Microsoft |          |           |              |       |           |   |
| Word format  |          |           |              |       |           |   |
| if possible) |          |           |              |       |           |   |
| i            |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
|              |          |           |              |       |           |   |
|              |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 1a. Identity |          |           |    Faron     |       |           |   |
| of the       |          |           | Pharmaceuticals |       |           |   |
| issuer or    |          |           |     Ltd      |       |           |   |
| the          |          |           |              |       |           |   |
| underlying   |          |           |              |       |           |   |
| issuer of    |          |           |              |       |           |   |
| existing     |          |           |              |       |           |   |
| shares to    |          |           |              |       |           |   |
| which voting |          |           |              |       |           |   |
| rights are   |          |           |              |       |           |   |
| attached ii: |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 1b. Please   |          |           |              |       |           |   |
| indicate if  |          |           |              |       |           |   |
| the issuer   |          |           |              |       |           |   |
| is a non-UK  |          |           |              |       |           |   |
| issuer       |          |           |              |       |           |   |
| (please mark |          |           |              |       |           |   |
| with an “X”  |          |           |              |       |           |   |
| if           |          |           |              |       |           |   |
| appropriate) |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Non-UK       |          |           |              |       |           | X |
| issuer       |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 2. Reason    |          |           |              |       |           |   |
| for the      |          |           |              |       |           |   |
| notification |          |           |              |       |           |   |
| (please mark |          |           |              |       |           |   |
| the          |          |           |              |       |           |   |
| appropriate  |          |           |              |       |           |   |
| box or boxes |          |           |              |       |           |   |
| with an “X”) |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| An           |          |           |              |       |           | X |
| acquisition  |          |           |              |       |           |   |
| or disposal  |          |           |              |       |           |   |
| of voting    |          |           |              |       |           |   |
| rights       |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| An           |          |           |              |       |           |   |
| acquisition  |          |           |              |       |           |   |
| or disposal  |          |           |              |       |           |   |
| of financial |          |           |              |       |           |   |
| instruments  |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| An event     |          |           |              |       |           |   |
| changing the |          |           |              |       |           |   |
| breakdown of |          |           |              |       |           |   |
| voting       |          |           |              |       |           |   |
| rights       |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Other        |          |           |              |       |           |   |
| (please      |          |           |              |       |           |   |
| specify)     |          |           |              |       |           |   |
| iii:         |          |           |              |       |           |   |
| Decrease of  |          |           |              |       |           |   |
| holdings     |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 3. Details   |          |           |              |       |           |   |
| of person    |          |           |              |       |           |   |
| subject to   |          |           |              |       |           |   |
| the          |          |           |              |       |           |   |
| notification |          |           |              |       |           |   |
| obligation   |          |           |              |       |           |   |
| iv           |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Name         |          |           | Blood Cancer |       |           |   |
|              |          |           | United, Inc. |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| City and     |          |           | Washington,  |       |           |   |
| country of   |          |           | D.C., United |       |           |   |
| registered   |          |           | States of    |       |           |   |
| office (if   |          |           | America      |       |           |   |
| applicable)  |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 4. Full name |          |           |              |       |           |   |
| of           |          |           |              |       |           |   |
| shareholder(s) |          |           |              |       |           |   |
| (if          |          |           |              |       |           |   |
| different    |          |           |              |       |           |   |
| from 3.) v   |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Name TAP BCU |          |           |              |       |           |   |
| Faron, LLC   |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| City and     |          |           | Newark,      |       |           |   |
| country of   |          |           | Delaware,    |       |           |   |
| registered   |          |           | United       |       |           |   |
| office (if   |          |           | States of    |       |           |   |
| applicable)  |          |           | America      |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 5. Date on   |          |           | 15/04/2026   |       |           |   |
| which the    |          |           |              |       |           |   |
| threshold    |          |           |              |       |           |   |
| was crossed  |          |           |              |       |           |   |
| or reached   |          |           |              |       |           |   |
| vi:          |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 6. Date on   |          |           | 14/05/2026   |       |           |   |
| which issuer |          |           |              |       |           |   |
| notified     |          |           |              |       |           |   |
| (DD/MM/YYYY): |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| 7. Total     |          |           |              |       |           |   |
| positions of |          |           |              |       |           |   |
| person(s)    |          |           |              |       |           |   |
| subject to   |          |           |              |       |           |   |
| the          |          |           |              |       |           |   |
| notification |          |           |              |       |           |   |
| obligation   |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
|              |   % of   |   % of    |              | Total | Total     |   |
|              |  voting  |  voting   |              |  of   | number of |   |
|              |  rights  |  rights   |              | both  | voting    |   |
|              | attached |  through  |              | in %  | rights    |   |
|              |    to    | financial |              | (8.A  | held in   |   |
|              |  shares  | instruments |              |   +   | issuer    |   |
|              |  (total  |           |              | 8.B)  | (8.A +    |   |
|              | of 8. A) | (total of |              |       | 8.B) vii  |   |
|              |          |  8.B 1 +  |              |       |           |   |
|              |          |  8.B 2)   |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Resulting    | 3.47%    |           |              | 3.47% | 7,037,426 |   |
| situation on |          |           |              |       |           |   |
| the date on  |          |           |              |       |           |   |
| which        |          |           |              |       |           |   |
| threshold    |          |           |              |       |           |   |
| was crossed  |          |           |              |       |           |   |
| or reached   |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+
| Position of  |          |           |              |       |           |   |
| previous     |          |           |              |       |           |   |
| notification |          |           |              |       |           |   |
| (if          |          |           |              |       |           |   |
| applicable)  |          |           |              |       |           |   |
+--------------+----------+-----------+--------------+-------+-----------+---+

+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
| 8. Notified  |      |      |      |      |      |      |      |      |      |
| details of   |      |      |      |      |      |      |      |      |      |
| the          |      |      |      |      |      |      |      |      |      |
| resulting    |      |      |      |      |      |      |      |      |      |
| situation on |      |      |      |      |      |      |      |      |      |
| the date on  |      |      |      |      |      |      |      |      |      |
| which the    |      |      |      |      |      |      |      |      |      |
| threshold    |      |      |      |      |      |      |      |      |      |
| was crossed  |      |      |      |      |      |      |      |      |      |
| or reached   |      |      |      |      |      |      |      |      |      |
| viii         |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| A: Voting    |      |      |      |      |      |      |      |      |      |
| rights       |      |      |      |      |      |      |      |      |      |
| attached to  |      |      |      |      |      |      |      |      |      |
| shares       |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| Class/type   |      |      |      |      |      |      | % of |      |      |
| of           |      | Number |      |      |      |      | voting |      |      |
| shares       |      | of   |      |      |      |      | rights |      |      |
| ISIN code    |      | voting |      |      |      |      |      |      |      |
| (if          |      | rights |      |      |      |      |      |      |      |
| possible)    |      | ix   |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      | Direct |      | Indirect |      |      | Direct |      | Indirect |
|              |      |      |      |      |      |      |      |      |      |
|              |      | (DTR5.1) |      | (DTR5.2.1) |      |      | (DTR5.1) |      | (DTR5.2.1) |
+--------------+------+------+------+------+------+------+------+------+------+
| FI4000153309 |      |      |      |      |      |      |      |      |      |
|              |      | 7,037,426 |      |      |      |      | 3.47% |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| SUBTOTAL 8.  |      |      |      |      |      |      |      |      |      |
| A            |      | 7,037,426 |      |      |      |      | 3.47% |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| B 1:         |      |      |      |      |      |      |      |      |      |
| Financial    |      |      |      |      |      |      |      |      |      |
| Instruments  |      |      |      |      |      |      |      |      |      |
| according to |      |      |      |      |      |      |      |      |      |
| DTR5.3.1R    |      |      |      |      |      |      |      |      |      |
| (1) (a)      |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| Type of      |      |      |      |      |      |      |      |      | % of |
| financial    |      | Expiration | Exercise/ |      |      | Number |      |      | voting |
| instrument   |      | date |      |      |      | of   |      |      | rights |
|              |      | x    |      |      |      | voting |      |      |      |
|              |      |      | Conversion |      |      | rights |      |      |      |
|              |      |      | Period |      |      | that |      |      |      |
|              |      |      | xi   |      |      | may  |      |      |      |
|              |      |      |      |      |      | be   |      |      |      |
|              |      |      |      |      |      | acquired |      |      |      |
|              |      |      |      |      |      | if   |      |      |      |
|              |      |      |      |      |      | the  |      |      |      |
|              |      |      |      |      |      | instrument |      |      |      |
|              |      |      |      |      |      | is   |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      | exercised/converted. |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      | SUBTOTAL |      |      |      |      |      |      |
|              |      |      | 8. B |      |      |      |      |      |      |
|              |      |      | 1    |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| B 2:         |      |      |      |      |      |      |      |      |      |
| Financial    |      |      |      |      |      |      |      |      |      |
| Instruments  |      |      |      |      |      |      |      |      |      |
| with similar |      |      |      |      |      |      |      |      |      |
| economic     |      |      |      |      |      |      |      |      |      |
| effect       |      |      |      |      |      |      |      |      |      |
| according to |      |      |      |      |      |      |      |      |      |
| DTR5.3.1R    |      |      |      |      |      |      |      |      |      |
| (1) (b)      |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
| Type of      |      |      |      |      |      |      |      |      | % of |
| financial    | Expiration |      | Exercise/ |      | Physical |      |      | Number | voting |
| instrument   | date |      |      |      | or   |      |      | of   | rights |
|              | x    |      |      |      | cash |      |      | voting |      |
|              |      |      | Conversion |      |      |      |      | rights |      |
|              |      |      | Period |      | Settlement |      |      |      |      |
|              |      |      | xi   |      | xii  |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      | SUBTOTAL |      |      |      |      |
|              |      |      |      |      | 8.B.2 |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
|              |      |      |      |      |      |      |      |      |      |
+--------------+------+------+------+------+------+------+------+------+------+

+--------------------------------+------------+-------------+------------+---+
| 9. Information in relation to  |            |             |            |   |
| the person subject to the      |            |             |            |   |
| notification obligation        |            |             |            |   |
| (please mark the               |            |             |            |   |
| applicable box with an “X”)    |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| Person subject to the          |            |             |            |   |
| notification obligation is not |            |             |            |   |
| controlled by any natural      |            |             |            |   |
| person or legal entity and     |            |             |            |   |
| does not control any other     |            |             |            |   |
| undertaking(s) holding         |            |             |            |   |
| directly or indirectly an      |            |             |            |   |
| interest in the (underlying)   |            |             |            |   |
| issuer xiii                    |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| Full chain of controlled       |            |             |            | X |
| undertakings through which the |            |             |            |   |
| voting rights and/or the       |            |             |            |   |
| financial instruments are      |            |             |            |   |
| effectively held starting with |            |             |            |   |
| the ultimate controlling       |            |             |            |   |
| natural person or legal entity |            |             |            |   |
| (please add additional rows as |            |             |            |   |
| necessary) xiv                 |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
|            Name xv             |    % of    | % of voting |  Total of  |   |
|                                |   voting   |   rights    | both if it |   |
|                                | rights if  |   through   | equals or  |   |
|                                | it equals  |  financial  | is higher  |   |
|                                |   or is    | instruments |  than the  |   |
|                                |   higher   |    if it    | notifiable |   |
|                                |  than the  |  equals or  | threshold  |   |
|                                | notifiable |  is higher  |            |   |
|                                | threshold  |  than the   |            |   |
|                                |            | notifiable  |            |   |
|                                |            |  threshold  |            |   |
+--------------------------------+------------+-------------+------------+---+
| Blood Cancer United, Inc. 100% | 0%         |             | 0%         |   |
| owner of TAP BCU, LLC          |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| TAP BCU, LLC. 100% owner of    | 0%         |             | 0%         |   |
| TAP BCU Faron, LLC             |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| TAP BCU Faron, LLC,            | 3.47%      |             | 3.47%      |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
|                                |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
|                                |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
|                                |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| 10. In case of proxy voting,   |            |             |            |   |
| please identify:               |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| Name of the proxy holder       |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| The number and % of voting     |            |             |            |   |
| rights held                    |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| The date until which the       |            |             |            |   |
| voting rights will be held     |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
|                                |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| 11. Additional information xvi |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+
| Providing information directly |            |             |            |   |
| to the Company as a result of  |            |             |            |   |
| meeting the threshold in the   |            |             |            |   |
| Company’s Arti-cles of         |            |             |            |   |
| Association (does not meet the |            |             |            |   |
| AIM regulatory notification    |            |             |            |   |
| threshold).                    |            |             |            |   |
|                                |            |             |            |   |
| Gordon G. Miller, Jr. (“JR     |            |             |            |   |
| Miller”), Executive Vice       |            |             |            |   |
| President & Chief Financial    |            |             |            |   |
| Officer Blood Cancer United,   |            |             |            |   |
| Inc. and authorized            |            |             |            |   |
| controlling person with        |            |             |            |   |
| respect to:                    |            |             |            |   |
|                                |            |             |            |   |
| Blood Cancer United, Inc., TAP |            |             |            |   |
| BCU, LLC and TAP BCU Faron,    |            |             |            |   |
| LLC                            |            |             |            |   |
| TAP BCU Faron, LLC, c/o Blood  |            |             |            |   |
| Cancer United, Inc. 1201 15th  |            |             |            |   |
| Street N.W., Suite 410,        |            |             |            |   |
| Washington, D.C. 20005 U.S.A.  |            |             |            |   |
|                                |            |             |            |   |
| +1.860.488.1774                |            |             |            |   |
|                                |            |             |            |   |
| Jr.Miller@bloodcancerunited.org |            |             |            |   |
|                                |            |             |            |   |
|                                |            |             |            |   |
| 3.47% of shares and voting     |            |             |            |   |
| rights is as per Faron         |            |             |            |   |
| Pharmaceuticals Ltd. request   |            |             |            |   |
| to include Treasury Shares in  |            |             |            |   |
| the denominator. The           |            |             |            |   |
| percentage is 3.527% if        |            |             |            |   |
| exclude Treasury Shares.       |            |             |            |   |
|                                |            |             |            |   |
+--------------------------------+------------+-------------+------------+---+

+-----------------------+-----------------------------------------------------+
| Place of completion   | Blood Cancer United, Inc. Washington, D.C. U.S.A.   |
+-----------------------+-----------------------------------------------------+
| Date of completion    | 14/05/2026                                          |
+-----------------------+-----------------------------------------------------+